Here are four points:
1. Zacks recently lowered EndoChoice from a “hold” rating to a “sell” rating.
2. EndoChoice has a 52-week low of $3.70 and a 52-week high of $19.69.
3. The company has a 50-day moving average price of $5.95 and a 200-day moving average price of $10.47.
4. The firm’s market capitalization is $108.35 million.
More articles on GI/endoscopy:
GI physician to know: Dr. Nicholas Shaheen of UNC Health Care
5 most read GI/endoscopy stories: Week of Feb. 15 — Feb. 19
Dr. Pankaj Vashi: 10 qualities to look for in a GI physician partner
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.